Citation

BibTex format

@article{Wise:2023:10.1002/alr.23090,
author = {Wise, SK and Damask, C and Roland, LT and Ebert, C and Levy, JM and Lin, S and Luong, A and Rodriguez, K and Sedaghat, AR and Toskala, E and Villwock, J and Abdullah, B and Akdis, C and Alt, JA and Ansotegui, IJ and Azar, A and Baroody, F and Benninger, MS and Bernstein, J and Brook, C and Campbell, R and Casale, T and Chaaban, M and Chew, FT and Chambliss, J and Cianferoni, A and Custovic, A and Davis, EM and DelGaudio, JM and Ellis, AK and Flanagan, C and Fokkens, WJ and Franzese, C and Greenhawt, M and Gill, A and Halderman, A and Hohlfeld, JM and Incorvaia, C and Joe, SA and Joshi, S and Kuruvilla, ME and Kim, J and Klein, AM and Krouse, HJ and Kuan, EC and Lang, D and Larenas-Linnemann, D and Laury, AM and Lechner, M and Lee, SE and Lee, VS and Loftus, P and Marcus, S and Marzouk, H and Mattos, J and McCoul, E and Melen, E and Mims, JW and Mullol, J and Nayak, JV and Oppenheimer, J and Orlandi, RR and Phillips, K and Platt, M and Ramanathan, M and Raymond, M and Rhee, C-S and Reit},
doi = {10.1002/alr.23090},
journal = {International Forum of Allergy and Rhinology},
pages = {293--859},
title = {International consensus statement on allergy and rhinology: Allergic rhinitis - 2023},
url = {http://dx.doi.org/10.1002/alr.23090},
volume = {13},
year = {2023}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BACKGROUND: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR-Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR-Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence-based findings and recommendation from the full document. METHODS: ICAR-Allergic Rhinitis 2023 employed established evidence-based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. RESULTS: ICAR-Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. CONCLUSION: The ICAR-Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.
AU - Wise,SK
AU - Damask,C
AU - Roland,LT
AU - Ebert,C
AU - Levy,JM
AU - Lin,S
AU - Luong,A
AU - Rodriguez,K
AU - Sedaghat,AR
AU - Toskala,E
AU - Villwock,J
AU - Abdullah,B
AU - Akdis,C
AU - Alt,JA
AU - Ansotegui,IJ
AU - Azar,A
AU - Baroody,F
AU - Benninger,MS
AU - Bernstein,J
AU - Brook,C
AU - Campbell,R
AU - Casale,T
AU - Chaaban,M
AU - Chew,FT
AU - Chambliss,J
AU - Cianferoni,A
AU - Custovic,A
AU - Davis,EM
AU - DelGaudio,JM
AU - Ellis,AK
AU - Flanagan,C
AU - Fokkens,WJ
AU - Franzese,C
AU - Greenhawt,M
AU - Gill,A
AU - Halderman,A
AU - Hohlfeld,JM
AU - Incorvaia,C
AU - Joe,SA
AU - Joshi,S
AU - Kuruvilla,ME
AU - Kim,J
AU - Klein,AM
AU - Krouse,HJ
AU - Kuan,EC
AU - Lang,D
AU - Larenas-Linnemann,D
AU - Laury,AM
AU - Lechner,M
AU - Lee,SE
AU - Lee,VS
AU - Loftus,P
AU - Marcus,S
AU - Marzouk,H
AU - Mattos,J
AU - McCoul,E
AU - Melen,E
AU - Mims,JW
AU - Mullol,J
AU - Nayak,JV
AU - Oppenheimer,J
AU - Orlandi,RR
AU - Phillips,K
AU - Platt,M
AU - Ramanathan,M
AU - Raymond,M
AU - Rhee,C-S
AU - Reitsma,S
AU - Ryan,M
AU - Sastre,J
AU - Schlosser,RJ
AU - Schuman,TA
AU - Shaker,MS
AU - Sheikh,A
AU - Smith,KA
AU - Soyka,MB
AU - Takashima,M
AU - Tang,M
AU - Tantilipikorn,P
AU - Taw,MB
AU - Tversky,J
AU - Tyler,MA
AU - Veling,MC
AU - Wallace,D
AU - Wang,DY
AU - White,A
AU - Zhang,L
DO - 10.1002/alr.23090
EP - 859
PY - 2023///
SN - 2042-6976
SP - 293
TI - International consensus statement on allergy and rhinology: Allergic rhinitis - 2023
T2 - International Forum of Allergy and Rhinology
UR - http://dx.doi.org/10.1002/alr.23090
UR - https://www.ncbi.nlm.nih.gov/pubmed/36878860
VL - 13
ER -